Paper11262391
Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.
Lucas PC and 8 others. J Biol Chem, 2001. Cited by 350 papers, by iCite.
Cite this record
ConductScience Library. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. Papers, record 11262391. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11262391
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adaptor Proteins, Signal Transducing | Major topic |
| Lymphoma, B-Cell, Marginal Zone | Major topic |
| NF-kappa B | Major topic |
| Neoplasm Proteins | Major topic |
| Translocation, Genetic | Major topic |
| B-Cell CLL-Lymphoma 10 Protein | |
| Blotting, Western | |
| Caspases | |
| Cell Line | |
| Chromosomes, Human, Pair 11 | |
| Chromosomes, Human, Pair 14 | |
| Chromosomes, Human, Pair 18 | |
| Enzyme Activation | |
| Humans | |
| I-kappa B Kinase | |
| Models, Biological | |
| Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | |
| Mutation | |
| Plasmids | |
| Precipitin Tests | |
| Protein Binding | |
| Protein Serine-Threonine Kinases | |
| Protein Structure, Tertiary | |
| Signal Transduction | |
| Transfection | |
| Tumor Cells, Cultured |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA84064 | NCI NIH HHS | United States | R01CA084064 | PubMed and NIH | NIH RePORTER |
| F32-CA88470-01 | NCI NIH HHS | United States | F32CA884700 | PubMed | NIH RePORTER |
| F32CA088470 | NIH | NIH RePORTER |
Cited by146
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 350 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41815811 | A novel mucosa-associated lymphoid tissue translocation gene 1-related immune prognostic signature and targeted drug screening for glioblastoma. | Brain Circ | 2026 | https://conductscience.org/library/papers/41815811 | PubMed |
| 41213928 | LUBAC modulates CBM complex functions downstream of TRAF6 in T cells. | Nat Commun | 2025 | https://conductscience.org/library/papers/41213928 | PubMed |
| 41209553 | Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma. | Int J Med Sci | 2025 | https://conductscience.org/library/papers/41209553 | PubMed |
| 40748513 | Loss of MALT1 Function in a Patient With Combined Immunodeficiency: a Novel Pathogenic Variant and Immunological Insights. | J Clin Immunol | 2025 | https://conductscience.org/library/papers/40748513 | PubMed |
| 40231473 | A small-molecule inhibitor of BCL10-MALT1 interaction abrogates progression of diffuse large B cell lymphoma. | J Clin Invest | 2025 | https://conductscience.org/library/papers/40231473 | PubMed |
| 40075237 | Targeting both death and paracaspase domains of MALT1 with antisense oligonucleotides overcomes resistance to immune-checkpoint inhibitors. | Nat Cancer | 2025 | https://conductscience.org/library/papers/40075237 | PubMed |
| 39845928 | NF-κB signaling is the major inflammatory pathway for inducing insulin resistance. | 3 Biotech | 2025 | https://conductscience.org/library/papers/39845928 | PubMed |
| 36930645 | CARD-only proteins regulate in vivo inflammasome responses and ameliorate gout. | Cell Rep | 2023 | https://conductscience.org/library/papers/36930645 | PubMed |
| 36899924 | Transcriptional Regulation during Aberrant Activation of NF-κB Signalling in Cancer. | Cells | 2023 | https://conductscience.org/library/papers/36899924 | PubMed |
| 36295095 | Novel Insights into Pathophysiology of Orbital Inflammatory Diseases and Progression to Orbital Lymphoma by Pathway Enrichment Analysis. | Life (Basel) | 2022 | https://conductscience.org/library/papers/36295095 | PubMed |
| 36158865 | Proteomic analysis of arylamine N-acetyltransferase 1 knockout breast cancer cells: Implications in immune evasion and mitochondrial biogenesis. | Toxicol Rep | 2022 | https://conductscience.org/library/papers/36158865 | PubMed |
| 35885021 | Bcl10 Regulates Lipopolysaccharide-Induced Pro-Fibrotic Signaling in Bronchial Fibroblasts from Severe Asthma Patients. | Biomedicines | 2022 | https://conductscience.org/library/papers/35885021 | PubMed |
| 35658124 | BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL. | Cancer Discov | 2022 | https://conductscience.org/library/papers/35658124 | PubMed |
| 35467421 | Porcine Reproductive and Respiratory Syndrome Virus Adapts Antiviral Innate Immunity via Manipulating MALT1. | mBio | 2022 | https://conductscience.org/library/papers/35467421 | PubMed |
| 35116108 | Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas. | World J Gastrointest Oncol | 2022 | https://conductscience.org/library/papers/35116108 | PubMed |
| 35079916 | Expanding the Clinical and Immunological Phenotypes and Natural History of MALT1 Deficiency. | J Clin Immunol | 2022 | https://conductscience.org/library/papers/35079916 | PubMed |
| 35008340 | Recent Advances in the Genetic of MALT Lymphomas. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/35008340 | PubMed |
| 33822844 | Regnase-1 is essential for B cell homeostasis to prevent immunopathology. | J Exp Med | 2021 | https://conductscience.org/library/papers/33822844 | PubMed |
| 32905547 | The adaptor protein CARD9, from fungal immunity to tumorigenesis. | Am J Cancer Res | 2020 | https://conductscience.org/library/papers/32905547 | PubMed |
| 32425939 | Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology. | Front Immunol | 2020 | https://conductscience.org/library/papers/32425939 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MALT1 | 10892 | Swiss-Prot's references | https://conductscience.org/library/genes/10892 | NCBI Gene |
| BCL10 | 8915 | PubTator's text mining | https://conductscience.org/library/genes/8915 | NCBI Gene |
| BIRC3 | 330 | PubTator's text mining | https://conductscience.org/library/genes/330 | NCBI Gene |
| CHUK | 1147 | PubTator's text mining | https://conductscience.org/library/genes/1147 | NCBI Gene |
| IKBKB | 3551 | PubTator's text mining | https://conductscience.org/library/genes/3551 | NCBI Gene |
| IKBKE | 9641 | PubTator's text mining | https://conductscience.org/library/genes/9641 | NCBI Gene |
| IKBKG | 8517 | PubTator's text mining | https://conductscience.org/library/genes/8517 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| RIPK1 | 8737 | PubTator's text mining | https://conductscience.org/library/genes/8737 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11262391
GET https://conductscience.org/api/papers/v1/11262391/cited_by?page=2